Wecomput

Wecomput™ is committed to driving innovative drug research and development with computational technology for the benefit of human health. Wecomput integrates artificial intelligence, biophysics, high-performance computing, generative biology, and other technologies to create a distinctive platform for drug molecule generation, design, and simulation. It aims to revolutionize traditional drug discovery methods and accelerate the R&D process of innovative drugs such as proteins, antibodies, and mRNA. The core team members come from internationally renowned AI pharmaceutical companies, leading pharmaceutical enterprises, well-known internet companies, and 985 universities, possessing rich experience, deep understanding, and great enthusiasm in interdisciplinary fields like pharmaceuticals, life sciences, artificial intelligence, and software development.